340 related articles for article (PubMed ID: 27193077)
1. Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology.
Galdeano C; Ciulli A
Future Med Chem; 2016 Sep; 8(13):1655-80. PubMed ID: 27193077
[TBL] [Abstract][Full Text] [Related]
2. Data-Driven Exploration of Selectivity and Off-Target Activities of Designated Chemical Probes.
Miljković F; Bajorath J
Molecules; 2018 Sep; 23(10):. PubMed ID: 30249057
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit.
Rianjongdee F; Atkinson SJ; Chung CW; Grandi P; Gray JRJ; Kaushansky LJ; Medeiros P; Messenger C; Phillipou A; Preston A; Prinjha RK; Rioja I; Satz AL; Taylor S; Wall ID; Watson RJ; Yao G; Demont EH
J Med Chem; 2021 Aug; 64(15):10806-10833. PubMed ID: 34251219
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective bivalent inhibitors of BET bromodomains.
Waring MJ; Chen H; Rabow AA; Walker G; Bobby R; Boiko S; Bradbury RH; Callis R; Clark E; Dale I; Daniels DL; Dulak A; Flavell L; Holdgate G; Jowitt TA; Kikhney A; McAlister M; Méndez J; Ogg D; Patel J; Petteruti P; Robb GR; Robers MB; Saif S; Stratton N; Svergun DI; Wang W; Whittaker D; Wilson DM; Yao Y
Nat Chem Biol; 2016 Dec; 12(12):1097-1104. PubMed ID: 27775716
[TBL] [Abstract][Full Text] [Related]
5. From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery.
Ferreira LG; Andricopulo AD
Curr Top Med Chem; 2017; 17(20):2260-2270. PubMed ID: 28240184
[TBL] [Abstract][Full Text] [Related]
6. Domain-selective targeting of BET proteins in cancer and immunological diseases.
Petretich M; Demont EH; Grandi P
Curr Opin Chem Biol; 2020 Aug; 57():184-193. PubMed ID: 32741705
[TBL] [Abstract][Full Text] [Related]
7. Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.
Hay DA; Fedorov O; Martin S; Singleton DC; Tallant C; Wells C; Picaud S; Philpott M; Monteiro OP; Rogers CM; Conway SJ; Rooney TP; Tumber A; Yapp C; Filippakopoulos P; Bunnage ME; Müller S; Knapp S; Schofield CJ; Brennan PE
J Am Chem Soc; 2014 Jul; 136(26):9308-19. PubMed ID: 24946055
[TBL] [Abstract][Full Text] [Related]
8. Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites.
Olp MD; Sprague DJ; Goetz CJ; Kathman SG; Wynia-Smith SL; Shishodia S; Summers SB; Xu Z; Statsyuk AV; Smith BC
ACS Chem Biol; 2020 Apr; 15(4):1036-1049. PubMed ID: 32149490
[TBL] [Abstract][Full Text] [Related]
9. Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains.
Dalle Vedove A; Spiliotopoulos D; D'Agostino VG; Marchand JR; Unzue A; Nevado C; Lolli G; Caflisch A
ChemMedChem; 2018 Jul; 13(14):1479-1487. PubMed ID: 29770599
[TBL] [Abstract][Full Text] [Related]
10. Targeting epigenetic reader domains by chemical biology.
Cipriano A; Sbardella G; Ciulli A
Curr Opin Chem Biol; 2020 Aug; 57():82-94. PubMed ID: 32739717
[TBL] [Abstract][Full Text] [Related]
11. Aiming to Miss a Moving Target: Bromo and Extra Terminal Domain (BET) Selectivity in Constrained ATAD2 Inhibitors.
Bamborough P; Chung CW; Furze RC; Grandi P; Michon AM; Watson RJ; Mitchell DJ; Barnett H; Prinjha RK; Rau C; Sheppard RJ; Werner T; Demont EH
J Med Chem; 2018 Sep; 61(18):8321-8336. PubMed ID: 30226378
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach.
Miller DC; Martin MP; Adhikari S; Brennan A; Endicott JA; Golding BT; Hardcastle IR; Heptinstall A; Hobson S; Jennings C; Molyneux L; Ng Y; Wedge SR; Noble MEM; Cano C
Org Biomol Chem; 2018 Mar; 16(11):1843-1850. PubMed ID: 29469144
[TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibitors of bromodomain-acetyl-lysine interactions.
Brand M; Measures AR; Wilson BG; Cortopassi WA; Alexander R; Höss M; Hewings DS; Rooney TP; Paton RS; Conway SJ
ACS Chem Biol; 2015 Jan; 10(1):22-39. PubMed ID: 25549280
[TBL] [Abstract][Full Text] [Related]
14. Clinical progress and pharmacology of small molecule bromodomain inhibitors.
Theodoulou NH; Tomkinson NC; Prinjha RK; Humphreys PG
Curr Opin Chem Biol; 2016 Aug; 33():58-66. PubMed ID: 27295577
[TBL] [Abstract][Full Text] [Related]
15. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.
Theodoulou NH; Bamborough P; Bannister AJ; Becher I; Bit RA; Che KH; Chung CW; Dittmann A; Drewes G; Drewry DH; Gordon L; Grandi P; Leveridge M; Lindon M; Michon AM; Molnar J; Robson SC; Tomkinson NC; Kouzarides T; Prinjha RK; Humphreys PG
J Med Chem; 2016 Feb; 59(4):1425-39. PubMed ID: 25856009
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the Selectivity of Protein-Protein and Small Molecule Interactions with Fluorinated Tandem Bromodomain Reader Proteins.
Kalra P; McGraw L; Kimbrough JR; Pandey AK; Solberg J; Cui H; Divakaran A; John K; Hawkinson JE; Pomerantz WCK
ACS Chem Biol; 2020 Nov; 15(11):3038-3049. PubMed ID: 33138352
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain.
Ma XR; Xu L; Xu S; Klein BJ; Wang H; Das S; Li K; Yang KS; Sohail S; Chapman A; Kutateladze TG; Shi X; Liu WR; Wen H
J Med Chem; 2021 Aug; 64(15):10997-11013. PubMed ID: 34279931
[TBL] [Abstract][Full Text] [Related]
18. Identification of Covalent Bromodomain Binders through DNA Display of Small Molecules.
Daguer JP; Zambaldo C; Abegg D; Barluenga S; Tallant C; Müller S; Adibekian A; Winssinger N
Angew Chem Int Ed Engl; 2015 May; 54(20):6057-61. PubMed ID: 25772490
[TBL] [Abstract][Full Text] [Related]
19. Bromodomain biology and drug discovery.
Zaware N; Zhou MM
Nat Struct Mol Biol; 2019 Oct; 26(10):870-879. PubMed ID: 31582847
[TBL] [Abstract][Full Text] [Related]
20. Chemical Proteomic Profiling of Bromodomains Enables the Wide-Spectrum Evaluation of Bromodomain Inhibitors in Living Cells.
Li X; Wu Y; Tian G; Jiang Y; Liu Z; Meng X; Bao X; Feng L; Sun H; Deng H; Li XD
J Am Chem Soc; 2019 Jul; 141(29):11497-11505. PubMed ID: 31246451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
